(US) Nipro (Japan) Novartis AG (Switzerland) Fresenius Kabi (US) Phillips Medisize (US) ICU Medical (US) Medmix (Switzerland) Ypsomed AG (Switzerland) SolM (US) MARKET SCOPE WHAT IS IN IT FOR YOU: INJECTABLE DRUG DELIVERY MARKET: GROWTH, SIZE, SHARE, AND TRENDS REPORT CONTENT GUIDE DELIVERED CUSTOMIZATIONS We have successfully delivered the following deep-dive customizations: RECENT DEVELOPMENTS Mar-25 : Johnson & Johnson Services, Inc
Their safety, efficacy, and quality have not been verified through the FDA approval process
In the SUSTAIN 8 study, patients with T2DM exhibited a lean mass decrease of 2.3 kg alongside a total weight loss of 5.3 kg, resulting in 43.4% of weight loss attributable to lean mass, while the ratio of lean mass to total mass increased by 1.2% from the baseline [111]
Norepinephrine, on the other hand, is linked to alertness and arousal, further influencing attention and response actions
uncertainty regarding its clinical studies